Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Two loss years in a row NBB
Negative result in 2023 and 2024.
-
Tight liquidity NBB
Cash and receivables cover 35 % of short-term debt in 2024; threshold 65 %.
-
Busy address KBO
24 other companies have their registered office at the same address; threshold 10.
-
Legal situation KBO
Opening faillissement according to the CBE.
Financials
Financial year 2024
OP2LYSIS DEVELOPMENT from Liège, company number BE0769816843, closed financial year 2024 with a result of € -116,187 after tax. For that financial year OP2LYSIS DEVELOPMENT recorded a gross margin of € -20,361 and equity of € 1.8 million. Compared with financial year 2023, the result moved from € -220,008 to € -116,187. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 18, 2025.
€ 1.8 million
▼ 2% vs 2023
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -116,187
▲ 47 % less loss than in 2023
Profit after tax over the fiscal year.
€ 41,415
▼ 93% vs 2023
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -482,416.
People and assets in 2024
1
▼ 0.9 vs 2023
Average over the fiscal year, from the social balance sheet.
€ 74,344
▼ 66% vs 2023
€ 74,300 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
Debts at end 2024
€ 999,668
▼ 13% vs 2023
Loans from banks and other lenders, long and short.
€ 17,819
▼ 77% vs 2023
Supplier invoices still open on the last day of the fiscal year.
€ 1,029
▼ 89% vs 2023
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | Change 2023 → 2024 | |
|---|---|---|---|---|
| Gross margin | € 88,763 | € -28,839 | € -20,361 | ▲ € 8,478 |
| Profit after taxes | € -146,221 | € -220,008 | € -116,187 | ▲ € 103,821 |
| Equity | € 1,437,028 | € 1,859,992 | € 1,822,074 | ▼ 2% |
| Total debts | € 1,472,663 | € 1,312,292 | € 1,209,473 | ▼ 8% |
| Cash | € 136,930 | € 558,876 | € 41,415 | ▼ 93% |
| Retained profit | € -146,221 | € -366,229 | € -482,416 | ▼ € 116,187 |
| Bank debt | € 1,301,653 | € 1,144,028 | € 999,668 | ▼ 13% |
| Balance sheet total | € 2,909,691 | € 3,172,285 | € 3,031,547 | ▼ 4% |
| Employees (FTE) | 1.7 | 1.9 | 1 | ▼ 0.9 |
Key figures of OP2LYSIS DEVELOPMENT, fiscal years 2022 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.
What happened to OP2LYSIS DEVELOPMENT?
What happened at OP2LYSIS DEVELOPMENT in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
OP2LYSIS DEVELOPMENT is active according to the CBE. Legal situation: Opening faillissement.
- New annual accounts for financial year 2024: loss of € 116,187. Source: NBB ↗
- New establishment in Herstal. KBO
- Christophe GAUDIN became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 146,221 loss in 2022 to € 116,187 loss in 2024.
On average € 52,200 of value added per employee in 2022.
A new publication or filing at OP2LYSIS DEVELOPMENT? We notify you, reason included.
Follow OP2LYSIS DEVELOPMENTDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind OP2LYSIS DEVELOPMENT is Christophe GAUDIN. The shares are held by OP2LYSIS (France) SAS (100%).
Directors
According to the 2024 annual accounts
Christophe GAUDIN
Director
since 2021
Shareholders
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Boulevard de Patience et Beaujonc 3
4000 Liège
Avenue du Parc Industriel 89
4041 Herstal
Active since 17 June 2021
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 24 companies are registered at this address.
All companies at this address →Hyloris Developments
€ 5.1 million revenue · 2025
ONCORADIOMICS
€ 2.4 million gross margin · 2025
DERMAX
€ 1.6 million revenue · 2025
Hyloris
€ 384,852 revenue · 2025
Hyloris Pharmaceuticals
€ 3.8 million revenue · 2025
+19 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0769.816.843
- VAT number
- BE 0769.816.843
- Registered office
- Boulevard de Patience et Beaujonc 3, 4000 Liège
- Names & denominations
- OP2LYSIS DEVELOPMENT
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Opening faillissement
- Start date
- 17 June 2021
- Peppol
- Not registered
- Activities · NACE
Speur- en ontwikkelingswerk op biotechnologisch gebied